A. E. Hird, D. E. Magee, D. C. Cheung, R. Matta, G. S. Kulkarni, and R. K. Nam, “Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation model”, CUAJ, vol. 14, no. 9, pp. E418–27, Mar. 2020.